BridgeMD
New treatment option for Colorectal Cancer
Official title Recurrence Rate After Endoscopic Resection of , Laterally Spreading Tumor Granular Type (LST-G) of the Colon and Rectum: Endoscopic Mucosal Resection vs. Endoscopic Submucosal Dissection
ClinicalTrials.gov ID: NCT06815406
What this study is testing
- What it's testing
- Colorectal cancer is one of the leading causes of cancer-related mortality worldwide. Early-stage non-polypoid neoplastic lesions, particularly Laterally Spreading Tumors - Granular Type (LST-G) larger than 20mm, require effective endoscopic removal to prevent malignant progression.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age ≥ 18 years.
- Diagnosis of Laterally Spreading Tumor - Granular Type (LST-G) ≥ 20 mm in the colon or rectum with an indication for endoscopic resection.
- Life expectancy \> 10 years.
- Ability to understand and sign the informed consent form, demonstrating comprehension of the study and willingness to participate.
You likely can't join if
- Diagnosis of Laterally Spreading Tumor - Non-Granular Type (LST-NG).
- Presence of depressed areas within the lesion.
- Lesions located on a scar or anastomosis site.
- Lesions classified as Kudo Vi or Vn pattern.
- History of chronic inflammatory bowel disease (e.g., ulcerative colitis, Crohn's disease).
- Diagnosis of hereditary polyposis syndromes (e.g., familial adenomatous polyposis, Lynch syndrome).
The study team makes the final eligibility decision.
Where it's taking place
- Bologna, Italy
- Genova, Italy
- Milan, Italy
- Modena, Italy
- Reggio Emilia, Italy
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bologna, Italy; Genova, Italy; Milan, Italy; Modena, Italy; Reggio Emilia, Italy. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.